Biotage® – Investor Relations – Annual General Meeting

Biotage AB launches share buy-back

Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013

Interim report January - March 2013

Biotage and Peptide Synthesis

Coming soon: Isolera™ Dalton - Flash Chromatography with Integrated Mass Identification

ISOLUTE® Myco SPE columns, a dedicated product for the efficient extraction of mycotoxins from food matrices

TLC-to-Step Gradient capability significantly reduces both purification time and solvent use

Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation

Biotage moving into Mass Directed Flash

Annual General Meeting 2013

	Protocol - AGM 2013 (Swedish)
	Annual Report 2012 (English)
	Notice - AGM 2013
	Nomination Committee Proposal
	The Board of Directors report pursuant Chapter 18 Section 4 and Chapter 19 Section 22 the Swedish Companies Act
	Item 17 - The Board of Directors proposal for a resolution on guidelines for compensation for the executive management
	Item 18 - The Board of Directors proposal for a reduction of the share capital through cancellation of treasury shares and a bonus issue
	Item 19 - The Board of Directors proposal on authorization for the board of directors to issue shares and/or convertibles
	Item 20 - The Board of Directors proposal for a resolution on authorization for the board of directors to aquire and transfer own shares
	Variable compensation for the executive management

Corporate Governance
	Introduction
	General Meeting
	Nomination Committee
	Board of Directors
	Compensation Committee
	Audit Committee
	Auditor
	Group Management
•	Annual General Meeting
	Corporate Governance Reports
	15 Largest Owners
	Incentive Programs and information about Variable Compensation to the Executive Management
	Articles of Association